Anti-CD137 has no influence on donor cell engraftment
| . | CD4+ T cells . | CD8+ T cells . | Non-T cells . |
|---|---|---|---|
| Control Ig | 87.29 ± 6.47 | 74.80 ± 10.95 | 83.23 ± 5.86 |
| Control Ig + anti-FasL | 91.22 ± 2.96 | 79.18 ± 5.94 | 84.67 ± 2.14 |
| Anti-CD137 | 85.68 ± 4.44 | 76.56 ± 10.77 | 77.67 ± 7.82 |
| Anti-CD137 + anti-FasL | 89.34 ± 1.73 | 90.42 ± 2.64 | 85.58 ± 1.27 |
| . | CD4+ T cells . | CD8+ T cells . | Non-T cells . |
|---|---|---|---|
| Control Ig | 87.29 ± 6.47 | 74.80 ± 10.95 | 83.23 ± 5.86 |
| Control Ig + anti-FasL | 91.22 ± 2.96 | 79.18 ± 5.94 | 84.67 ± 2.14 |
| Anti-CD137 | 85.68 ± 4.44 | 76.56 ± 10.77 | 77.67 ± 7.82 |
| Anti-CD137 + anti-FasL | 89.34 ± 1.73 | 90.42 ± 2.64 | 85.58 ± 1.27 |
Experiments were performed as described in the legend of Figure 5. Splenocytes were isolated and stained for Ly9.1 and CD4 or CD8. Percent of donor cells in the respective cell population was shown as mean ± standard deviation (n = 6–7 mice per group).